RSWA
IDXX icon

Robinson Smith Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Robinson Smith Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-380
Closed -$243K – 88
2025
Q3 		$243K Sell
380
-3
-0.8% -$1.82K 0.17% 74
2025
Q2 		$205K Buy
+383
New +$183K 0.16% 86
2024
Q3 		– Sell
-465
Closed -$227K – 87
2024
Q2 		$227K Buy
465
+33
+8% +$16.6K 0.2% 80
2024
Q1 		$233K Hold
432
– – 0.22% 70
2023
Q4 		$240K Buy
+432
New +$203K 0.24% 77

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Robinson Smith Wealth Advisors's IDXX Position: Q4 2025 in Review

Robinson Smith Wealth Advisors sold out of Idexx Laboratories (IDXX) in Q4 2025, closing a stake of 380 shares — an estimated $243K sold.

Robinson Smith Wealth Advisors first reported a position in IDXX in Q4 2023 and held it in 5 quarters. The position peaked at $243K in Q3 2025. 1,386 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.

  • Robinson Smith Wealth Advisors reported no remaining Idexx Laboratories position as of Q4 2025 after selling out during the quarter.
  • Robinson Smith Wealth Advisors sold 380 Idexx Laboratories shares in Q4 2025, an estimated $243K.
  • Robinson Smith Wealth Advisors first reported a position in Idexx Laboratories in Q4 2023 and held it in 5 quarters.
  • Robinson Smith Wealth Advisors's Idexx Laboratories position peaked at $243K in Q3 2025.
  • 1,386 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.

Based on Robinson Smith Wealth Advisors's 13F filing for Q4 2025, filed 9 Feb 2026.